Amphastar Pharmaceuticals
AMPH
$41.11
Share price
0.69%
Change (1 day)
7.73%
Change (1 year)
Categories
Amphastar Pharmaceuticals (AMPH) - Net assets
Net assets on the balance sheet as of December 2023 : $0.63 B
According to Amphastar Pharmaceuticals's latest financial reports the company has $0.63 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Amphastar Pharmaceuticals - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.63 B | 20.95% |
| 2022-12-31 | $0.52 B | 18.66% |
| 2021-12-31 | $0.44 B | -0.71% |
| 2020-12-31 | $0.44 B | 4.96% |
| 2019-12-31 | $0.42 B | 17.34% |
| 2018-12-31 | $0.36 B | 9.18% |
| 2017-12-31 | $0.33 B | 1.36% |
| 2016-12-31 | $0.32 B | 11.42% |
| 2015-12-31 | $0.29 B | 4.84% |
| 2014-12-31 | $0.28 B | 12.05% |
| 2013-12-31 | $0.25 B | 7.76% |
| 2012-12-31 | $0.23 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Tonix Pharmaceuticals TNXP | $0.12 B | -81.10% | 🇺🇸 USA |
 SCYNEXIS SCYX | $91.99 M | -85.61% | 🇺🇸 USA |
 Marinus Pharmaceuticals MRNS | $16.76 M | -97.38% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | -$12.42 M | -101.94% | 🇺🇸 USA |